Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Metastatic neuroendocrine tumors mimicking as primary ocular disease.

Metastatic neuroendocrine tumors mimicking as primary ocular disease. American journal of ophthalmology case reports Shen, A., Haghighi, A., Liang, T., Lee, O., Gange, W., DeBoer, C., Akhter, M., Saber, M. S., Patel, V. R., Berry, J. L., Gokoffski, K. K. 2022; 26: 101425

Abstract

PURPOSE: To report two cases of metastatic neuroendocrine tumors masquerading as primary ocular disease.OBSERVATIONS: Case 1 is a 38-year-old man who was referred with subacute onset diplopia and fluctuating ptosis suggestive of myasthenia gravis. Case 2 is a 21-year-old man who presented with blurry vision and was found to have a pigmented ciliary body mass and retinal detachment suggestive of uveal melanoma. Both patients were ultimately diagnosed with metastatic neuroendocrine tumors.CONCLUSIONS AND IMPORTANCE: Neuroendocrine tumors, though rare and infrequently metastatic to the eye and orbit, can initially present with ocular signs. A broad differential and careful consideration of ocular and systemic symptoms are critical in such challenging cases.

View details for DOI 10.1016/j.ajoc.2022.101425

View details for PubMedID 35243162